SCHEMBL379855

SCHEMBL379855

CCc1ccc(C2C(O)[C@@]3(O)C(c4ccc(CC)cc4)[C@@](O)([C@H](O)CO)[C@@]23O)cc1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC5A2 P31639 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL815322 0.95 ADCY2 (0.32) SLC5A2
SCHEMBL1221653 0.95 SLC5A2 (0.32) SLC5A2
SCHEMBL813371 0.95 SLC5A2 (0.32) SLC5A2
SCHEMBL812905 0.95 SLC5A2 (0.32) SLC5A2
SCHEMBL5202375 0.93 SLC5A2 (0.34) SLC5A2
SCHEMBL9792009 0.90 CYP4A11 (0.37)
SCHEMBL468521 0.90
SCHEMBL6461064 0.90 SLC5A2 (0.32) SLC5A2
SCHEMBL468461 0.88 ALDH1A1 (0.35)
SCHEMBL8002891 0.86 SPHK1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 799 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935454-B1 HDPE-BASED BUFFER TUBES WITH IMPROVED EXCESS FIBER LENGTH IN FIBER OPTIC CABLES DOW GLOBAL TECHNOLOGIES LLC (US) 2018-02-21 EP claimed
US-9421266-B2 Safety of pseudoephedrine drug products PISGAH LABORATORIES, INC. (US) 2016-08-23 US claimed
EP-1765843-B1 PROCESS FOR PREPARING A PULVERULENT ALDITOL ACETAL COMPOSITION BASF SE (DE) 2016-05-18 EP claimed
EP-2408892-B1 STRUCTURED FLUID DETERGENT COMPOSITIONS COMPRISING DIBENZYLIDENE SORBITOL ACETAL DERIVATIVES PROCTER & GAMBLE (US) 2016-01-06 EP claimed
US-20150315355-A1 HDPE-Based Buffer Tubes with Improved Excess Fiber Length in Fiber Optic Cables DOW GLOBAL TECHNOLOGIES LLC 2015-11-05 US claimed
US-20140178480-A1 SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS PISGAH LABORATORIES, INC. 2014-06-26 US claimed
US-20130210973-A1 PROCESS FOR IMPROVING THE FLOW PROPERTIES OF POLYMER MELTS BASF SE (DE) 2013-08-15 US claimed
EP-2408893-B1 STRUCTURED FLUID DETERGENT COMPOSITIONS COMPRISING DIBENZYLIDENE POLYOL ACETAL DERIVATIVES AND DETERSIVE ENZYMES PROCTER & GAMBLE (US) 2013-04-17 EP claimed
US-8293697-B2 Structured fluid detergent compositions comprising dibenzylidene sorbitol acetal derivatives THE PROCTER & GAMBLE COMPANY (US) 2012-10-23 US claimed
EP-1597305-B1 POLYMER GEL-PROCESSING TECHNIQUES AND HIGH MODULUS PRODUCTS OMLIDON TECHNOLOGIES LLC (CH) 2012-10-10 EP claimed
EP-0801102-A2 Additive mixture having nucleating action for synthetic resin matters HOECHST AKTIENGESELLSCHAFT (DE) 1997-10-15 EP claimed
EP-0522558-B1 Process for stabilizing dibenzylidenesorbitols and composition thereof MITSUI TOATSU CHEMICALS (JP) 1996-09-11 EP claimed
US-5548007-A Radiation-resistant polypropylene resin composition MITSUI TOATSU CHEMICALS, INC. (JP) 1996-08-20 US claimed
US-5548008-A SYNDIOTACTIC; CONTAINS AT LEAST ONE ADDITIVE FROM PHOSPHORUS-OR AMINE-CONTAINING ANTIOXIDANTS AND A NUCLEATING AGENT MITSUI TOATSU CHEMICALS, INC. (JP) 1996-08-20 US claimed
EP-0361087-B1 Crystalline polyolefin composition CHISSO CORP (JP) 1996-07-10 EP claimed
US-5278216-A Comprising a nucleating agent MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1994-01-11 US claimed
US-5241080-A Mixture of a dibenzylidenesorbital and sorbic acid and/or potassium sorbate having storage stability MITSUI TOATSU CHEMICALS, INC. (JP) 1993-08-31 US claimed
EP-0522558-A2 Process for stabilizing dibenzylidenesorbitols and composition thereof MITSUI TOATSU CHEMICALS, Inc. (JP) 1993-01-13 EP claimed
EP-0419677-A1 SYNDIOTACTIC POLYPROPYLENE RESIN COMPOSITION MITSUI TOATSU CHEMICALS, Inc. (JP) 1991-04-03 EP claimed
US-5001176-A Crystalline polyolefin composition CHISSO CORPORATION (JP) 1991-03-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140178480-A1 SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS SORD, ABCB11, ABCB1 SLC5A2 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.